Nevada 2025 Regular Session

Nevada Assembly Bill AB411

Introduced
3/12/25  
Refer
3/12/25  
Report Pass
4/10/25  
Engrossed
4/22/25  
Refer
4/23/25  
Report Pass
5/16/25  
Enrolled
5/29/25  

Caption

Revises provisions relating to prescription drugs. (BDR 54-1100)

Companion Bills

No companion bills found.

Previously Filed As

NV SB354

Revises provisions relating to health insurance coverage of prescription drugs. (BDR 57-1041)

NV SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

NV AB259

Establishes provisions governing prescription drugs. (BDR 40-165)

NV SB294

Revises provisions relating to physician assistants. (BDR 54-965)

NV AB186

Revises provisions governing pharmacists. (BDR 54-344)

NV AB183

Revises provisions relating to optometry. (BDR 54-151)

NV LD538

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives

NV SB289

Relating to prescription drugs.

NV SB299

Enacts provisions relating to cost-sharing for prescription drugs

NV H7185

Provides that the prescription label for medication abortion prescription drugs may include the name of the dispensing healthcare practice instead of the name of the dispenser.

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

AZ HB2434

Controlled substances prescription monitoring program

IA SF117

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(See SF 313.)

IA HF2205

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.

IA SF313

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(Formerly SF 117.)

NJ A289

Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.

MS HB956

Opioid drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.

HI HB872

Relating To Health.